Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK

<p><strong>Objectives</strong> To explore UK clinicians’ beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer.</p> <p><strong>Design</strong> Cross-sectional online survey.</p> <p><stron...

ver descrição completa

Detalhes bibliográficos
Principais autores: Brett, J, Davies, EL, Matley, F, Aveyard, P, Wells, M, Foxcroft, D, Nicholson, B, De Silva Minor, S, Sinclair, L, Jakes, S, Watson, E
Formato: Journal article
Idioma:English
Publicado em: BMJ Publishing Group 2020
Descrição
Resumo:<p><strong>Objectives</strong> To explore UK clinicians’ beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer.</p> <p><strong>Design</strong> Cross-sectional online survey.</p> <p><strong>Setting</strong> England, Wales, Scotland and Northern Ireland.</p> <p><strong>Participants</strong> Clinicians involved in the care of patients with cancer.</p> <p><strong>Primary and secondary outcomes</strong> Behavioural Change Wheel capability, opportunity and motivation to perform a behaviour, knowledge, beliefs, current practice around e-cigarettes and other smoking cessation practices.</p> <p><strong>Method</strong> Clinicians (n=506) completed an online survey to assess beliefs and behaviours around e-cigarettes and other smoking cessation practices for patients with cancer. Behavioural factors associated with recommending e-cigarettes in practice were assessed.</p> <p><strong>Results</strong> 29% of clinicians would not recommend e-cigarettes to patients with cancer who continue to smoke. Factors associated with recommendation include smoking cessation knowledge (OR 1.56, 95% CI 1.01 to 2.44) and e-cigarette knowledge (OR 1.64, 95% CI 1.06 to 2.55), engagement with patients regarding smoking cessation (OR 2.12, 95% CI 1.12 to 4.03), belief in the effectiveness of e-cigarettes (OR 2.36 95% CI 1.61 to 3.47) and belief in sufficient evidence on e-cigarettes (OR 2.08 95% CI 1.10 to 4.00) and how comfortable they felt discussing e-cigarettes with patients (OR 1.57 95% CI 1.04 to 2.36).</p> <p><strong>Conclusion</strong> Many clinicians providing cancer care to patients who smoke do not recommend e-cigarettes as a smoking cessation aid and were unaware of national guidance supporting recommendation of e-cigarettes as a smoking cessation aid.</p>